Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Ares Capital's dividend looks tempting to many income investors, but sustainability hinges on cash flow, loan quality...
As SpaceX eyes a public debut, investors wonder if spacex could worth more than Tesla from day one. This article brea...
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
Chemed has faced a challenging year, even as its business lines stay essential. This article breaks down the drivers ...
Amazon’s stock is sliding this year as cloud rivals tighten the race and the company leans into a big AI investment. ...
A prominent investment firm stepped into Black Hills Corporation, driving a 22% gain over the year. This article brea...
A private AI startup is offering a sub-$1 pre-IPO round open to retail investors, pricing shares at $0.66 and promisi...
An AI model branded as WarrenAI outlines a bifurcated Bitcoin path for late 2026: a resilient floor around $50k-$55k ...
Public zoning records can be helpful for planning, but they also attract scammers. This article explains how those de...